| Literature DB >> 34103678 |
Sabrina C Behr1, Christopher Platen1, Pascal Vetter2, Nicole Heussen3,4, Steffen Leonhardt2, Thorsten Orlikowsky1, Konrad Heimann5.
Abstract
BACKGROUND: Magnetic induction measurement (MIM) is a noninvasive method for the contactless registration of respiration in newborn piglets by using measurement coils positioned at the bottom of an incubator. Acute pulmonary problems may be determinants of poor neurological and psychomotor outcomes in preterm infants. The current study tested the detection of pulmonary ventilation disorders via MIM in 11 newborn piglets.Entities:
Mesh:
Year: 2021 PMID: 34103678 PMCID: PMC9122816 DOI: 10.1038/s41390-021-01594-4
Source DB: PubMed Journal: Pediatr Res ISSN: 0031-3998 Impact factor: 3.953
Fig. 1Axial gradiometer topology.
Principle of axial gradiometer-based MIM, modified from ref. [2].
Experimental setup.
| 1. Induction of inhalation anesthesia with 2% isoflurane |
| 2. Placement of intravenous access at one ear |
| 3. Intravenous sedation with midazolame 0.1 mg/kg. Continuous infusion with ketamine (1 ml + 9 ml NaCl 0.9%): 0.6 ml/h → 6 mg/h, midazolame (purely) 0.6 ml/h → 3 mg/h. Monitoring using ECG and pulse oximetry at all four extremities |
| 4. Placement of second venous access at the other ear |
| 5. Intravenous parenteral dextrose infusion with Pädiafusin® I/Ringer®-Lsg. (Baxter, Unterschleißheim, Germany). Premedication for intubation with pentobarbital (1 ml + 15 ml NaCl 0.9%) 1 ml → 10 mg intravenously, fentanyl (1 ml + 9 ml NaCl) 2 ml → 10 mg intravenously |
| 6. Intubation with 3.5 mm endotracheal tube with surfactant channel up to tag 11 |
| 7. Initial ventilation via manual ventilation bag, then with respirator (frequency 40, p max 15, flow 8, PEEP 5), later p max 10 over 60 min |
| 8. Vital parameter measurement: conventional via ECG and pulse oximetry and via MIM. Measurement of arterial access with subsequent BGA monitoring of respiratory settings. Blood pressure monitoring via arterial access |
| 9. Malposition of endotracheal tube: ventilation of animal is stopped five times each for 1 min, while vital parameters are measured both conventionally and via MIM |
| 10. Atelectasis: the tube is introduced into the right lung → position check via X-ray. Synchronously, vital parameters are measured conventionally and by MIM in different positions. Thereafter, the “reopening” of the lung is documented via electrical impedance tomography if possible |
| 11. Pneumothorax: placement of an intrapleural catheter, position check via X-ray. Then, intrapleural insufflation of 20 ml of air → radiological check of the degree of pneumothorax |
| 12. Aspiration: 20 ml of NaCl 0.9% is applied intrapleurally and 10 ml is applied intrapulmonarily via surfactant channel |
| 13. Finalization of the animal experiment with 70 mg of pentobarbital intravenously |
During monitoring, as required: Bolus midazolame = 0.5 ml ≙ 0.5 mg Bolus ketamine = 0.4 ml ≙ 4 mg Bolus fentanyl = 2 ml ≙ 10 µg Bolus pentobarbital = 1 ml ≙ 10 mg |
| Continuous infusion: 10 ml of ketamine in 50 ml (concentration 10 mg/ml); 10 ml midazolame in 50 ml (concentration 5 mg/ml) |
Bolus administration: • 20 ml syringe midazolame (concentration 1 mg/ml); 20 ml syringe ketamine (concentration 10 mg/ml) • 20 ml syringe fentanyl (concentration 5 µg/ml) • 20 ml syringe pentobarbital (concentration 10 mg/ml) • Midazolame (Dormicum®) (pure) 5 mg/ml® 1 ml + 4 ml NaCl 0.9% for 1 mg/ml • Ketamine (pure) 100 mg/ml® 1 ml + 9 ml NaCl 0.9% for 10 mg/ml • Fentanyl (pure) 50 µg/ml® 1 ml + 9 ml NaCl 0.9% for 5 µg/ml • Pentobarbital (Narcoren®) (pure) 160 mg/ml; 1 ml + 15 ml NaCl 0.9% for 10 mg/ml |
Fig. 2Experimental incubator.
Setup of the measurement system at the bottom of the experimental incubator (coils 1–6).
Fig. 3X-ray.
Chest X-ray of an experimental animal (a) tube malposition and (b) pneumothorax.
Data (mean, SD) of heart rate and oxygen saturation of the experimental animals after induction of apnea 1–5, tube malposition, pneumothorax, and aspiration.
| Variable | Apnea 1 | Apnea 2 | Apnea 3 | Apnea 4 | Apnea 5 | Tube malf. | Pneumothorax | Aspiration | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
| Heart rate | 125.2 | 21.3 | 119.0 | 20.4 | 125.1 | 31.0 | 116.2 | 22.5 | 105.5 | 18.0 | 101.7 | 17.3 | 100.1 | 21.1 | 105.0 | 31.7 |
| Oxygen saturation | 98.3 | 3.7 | 97.7 | 2.9 | 98.7 | 2.9 | 98.5 | 3.3 | 97.9 | 3.7 | 99.0 | 2.6 | 69.4 | 36.2 | 49.7 | 39.7 |
Fig. 4Flow reference and MIM signal.
Comparison of a reference signal (blue) and MIM (red) during wash-out time (a) and after induction of an apnea (b).
P value from the comparison of the six measurement coils after induction of pathology (apnea 1–5, tube malposition, pneumothorax, aspiration) to the reference measurement/signal.
| Pathology | Coil 1 | Coil 2 | Coil 3 | Coil 4 | Coil 5 | Coil 6 |
|---|---|---|---|---|---|---|
| Apnea 1 | 0.2861 | 0.0975 | 0.0532 | 0.1432 | ||
| Apnea 2 | 0.7826 | 0.0680 | 0.1283 | |||
| Apnea 3 | 0.1876 | 0.1331 | 0.1062 | 0.1065 | ||
| Apnea 4 | 0.1161 | |||||
| Apnea 5 | 0.7511 | 0.6018 | 0.0535 | 0.2354 | ||
| Tube malposition | 0.1661 | 0.1058 | 0.0547 | 0.7600 | 0.8454 | |
| Pneumothorax | 0.0812 | 0.0936 | 0.8580 | |||
| Aspiration | 0.2185 | 0.7474 | 0.8681 | 0.1190 | 0.8555 | 0.6878 |
Statistically significant p-values are in bold.